Loading clinical trials...
Loading clinical trials...
Phase II Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer
Conditions
Interventions
Paclitaxel
Cisplatin
+1 more
Locations
1
Denmark
Department of Oncology 5073, Rigshospitalet
Copenhagen, Denmark
Start Date
September 1, 2007
Primary Completion Date
February 1, 2012
Completion Date
October 1, 2016
Last Updated
October 3, 2017
NCT07218913
NCT07106827
NCT06814496
NCT06954233
NCT06673329
NCT05670938
Lead Sponsor
Rigshospitalet, Denmark
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions